Evaluating the Diagnostic Efficacy and Results of Comprehensive SARS-CoV-2 Testing in Asymptomatic Individuals - Top-Institutions - MDSpire

Evaluating the Diagnostic Efficacy and Results of Comprehensive SARS-CoV-2 Testing in Asymptomatic Individuals

  • By

  • Marvin Weiss

  • Pascal Urwyler

  • Matthias von Rotz

  • Richard Kuehl

  • Sabine Kuster

  • Isabelle Vock

  • Lisandra Aguilar-Bultet

  • Fabian C. Franzeck

  • Claudia Bagutti

  • Katharina Rentsch

  • Stefano Bassetti

  • Karoline Leuzinger

  • Sarah Tschudin-Sutter

  • April 8, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Basel
    University Hospital Basel

    Basel, Switzerland

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Epidemiology

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Public Health

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Hospital Epidemiology

  • #4

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Infectious Diseases
    • Virology
    • Public Health

  • #5

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Public Health
    • Infectious Diseases
    • Epidemiology

Original Source(s)

Evaluating the Diagnostic Efficacy and Results of Comprehensive SARS-CoV-2 Testing in Asymptomatic Individuals

  • by Marvin Weiss, Pascal Urwyler, Matthias von Rotz, Richard Kuehl, Sabine Kuster, Isabelle Vock, Lisandra Aguilar-Bultet, Fabian C. Franzeck, Claudia Bagutti, Katharina Rentsch, Stefano Bassetti, Karoline Leuzinger, Sarah Tschudin-Sutter

  • April 8, 2026

Related Content

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Recent COVID-19 Shot Linked to Less Spread

Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.